top of page

Topic

Non-Muscle Invasive Bladder Cancer (NMIBC)

31 Podcasts • 3 Courses on BackTable

Hear how experienced physicians manage Non-Muscle Invasive Bladder Cancer (NMIBC) on BackTable. Learn from podcasts, cases, and courses curated by physician content creators, covering diagnosis, clinical decision-making, and treatments. Get the BackTable app to follow this Topic and hear more of the conversations that matter to your practice.

Bladder Cancer in the Community: Meeting Patients Where They Are
00:00 / 01:04

Save your progress. Continue watching on the BackTable app.

BackTable Urology

Episode # 316  •  14 Jul 2026

Bladder Cancer in the Community: Meeting Patients Where They Are

As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this episode of BackTable Urology, community urologic oncologist Dr. Adam Gadzinski joins Dr. Ruchika Talwar to discuss how evolving therapies for non–muscle-invasive bladder cancer (NMIBC) are changing the landscape for both patients and providers. They explore the financial, logistical, and workflow hurdles to adopting new treatments in community settings, as well as the unique opportunities for expanding access through local clinical trials.

More on Non-Muscle Invasive Bladder Cancer (NMIBC)

Loading recent podcasts…

Urology

Urology # 316

Jul 14, 2026

with Dr. Adam Gadzinski, Dr. Ruchika Talwar

Bladder Cancer in the Community: Meeting Patients Where They Are

As bladder cancer treatment options expand, so do the challenges of delivering them in real-world practice. On this...

Urology

Urology # 310

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

880+ listens

Tumor Board

Tumor Board # 65

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

130+ listens

Tumor Board

Tumor Board # 63

Jun 4, 2026

with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt

Launching Co-Managed APP/MD Clinics for Bladder Cancer

Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...

260+ listens

Tumor Board

Tumor Board # 67

Jun 18, 2026

with Dr. Sunil Patel, Dr. Kristen Scarpato, Dr. Bogdana Schmidt

Bladder Cancer Risk Stratification: Best Practices

Why does up to 10% of bladder cancer pathology change on expert review, and what does that mean for your intermediate...

30+ listens

Urology

Urology # 308

Jun 11, 2026

with Dr. Kelly Bree, Meredith Donahue NP, Dr. Saum Ghodoussipour, Dr. Vignesh Packiam

Navigating Shared Decision-Making in Bladder Cancer Treatment

What matters most to patients with non-muscle invasive bladder cancer (NMIBC)? In this episode of BackTable Urology,...

900+ listens

Industry

Industry # 101

Jun 9, 2026

with Dr. Ruchika Talwar, Anish Parikh

Keeping Up With Changes in Urologic Oncology & General Urology

Are academic medical conferences falling short when it comes to preparing clinicians for the unpredictable realities of...

290+ listens

Urology

Urology # 306

Jun 4, 2026

with Dr. Amy Luckenbaugh, Meredith Donahue NP, Dr. Bogdana Schmidt

Launching Co-Managed APP/MD Clinics for Bladder Cancer

Are traditional bladder cancer care models falling behind as new therapies flood the field and reshape the landscape?...

750+ listens

The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.

bottom of page